Clarify
250mg
-
Mode of action
Clarify inhibits protein synthesis by binding to 50s ribosomal subunits of susceptible organisms. It has activity against susceptible streptococci and staphylococci as well as other species including B catarrhalis, L spp, C. Travhomans and U urealyticum,
-
Indication
- Respiratory tract infection
- Skin and soft tissue infection
- Leprosy
- Peptic ulcer diseases
- Pharyngitis
- Tonsillitis
- Acute maxillary sinusitis
- Acute bacterial exacerbation of chronic bronchitis
- Pneumonia
- Legionellosis
- Helicobacter pylori
- Lyme disease
- Community acquired pneumonia